RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24827165http://www.w3.org/2000/01/rdf-schema#comment"Amyloid precursor protein (APP) and β-site APP cleaving enzyme (BACE-1) play important roles in the pathogenesis of Alzheimer's disease (AD). In this study, using bioinformatics analysis, we demonstrate that miR-384 is a microRNA (miRNA or miR) predicted to potentially target the 3' untranslated regions (3'-UTRs) of both APP and BACE-1. SH-SY5Y cells were transfected with miR-384 mimic oligonucleotide, miR-384 inhibitor oligonucleotide, or a non-specific control siRNA. We found that the overexpression of miR-384 suppressed the mRNA and protein expression of both APP and BACE-1. The miR-384 inhibitor oligonucleotide induced the upregulation of APP and BACE-1. The activity of BACE-1 was altered following the change in its protein expression. The binding sites of miR-384 on the 3'-UTRs of APP and BACE-1 were identified by luciferase assay. Furthermore, cells were treasted with amyloid-β (Aβ)42. Aβ42 downregulated miR-384 expression, leading to the continuous reduction in miR-384 expression. In addition, using a mouse model of AD, as well as patients with mild cognitive impairment (MCI) and dementia of Alzheimer's type (DAT), we examined the levels of miR-384 in cerebral spinal fluid (CSF) and serum. Patients with MCI and DAT had lower blood miR-384 levels compared with the controls. In addition, patients with DAT had lower blood miR-384 levels in blood compared with the MCI group. We also found decreased miR-384 expression in the several cerebral spinal fluid (CSF) of the patients with DAT. Negative correlations were observed between miR-384 and Aβ42 in the serum and CSF from patients with AD. In conclusion, these findings demonstrate that miR-384 may plays a role in the development of AD and may be a potential non-invasive biomarker for the diagnosis of AD."xsd:string
http://purl.uniprot.org/citations/24827165http://purl.org/dc/terms/identifier"doi:10.3892/ijmm.2014.1780"xsd:string
http://purl.uniprot.org/citations/24827165http://purl.uniprot.org/core/author"Li L."xsd:string
http://purl.uniprot.org/citations/24827165http://purl.uniprot.org/core/author"Wang J.L."xsd:string
http://purl.uniprot.org/citations/24827165http://purl.uniprot.org/core/author"Wang P.C."xsd:string
http://purl.uniprot.org/citations/24827165http://purl.uniprot.org/core/author"Liu C.G."xsd:string
http://purl.uniprot.org/citations/24827165http://purl.uniprot.org/core/date"2014"xsd:gYear
http://purl.uniprot.org/citations/24827165http://purl.uniprot.org/core/name"Int J Mol Med"xsd:string
http://purl.uniprot.org/citations/24827165http://purl.uniprot.org/core/pages"160-166"xsd:string
http://purl.uniprot.org/citations/24827165http://purl.uniprot.org/core/title"MicroRNA-384 regulates both amyloid precursor protein and beta-secretase expression and is a potential biomarker for Alzheimer's disease."xsd:string
http://purl.uniprot.org/citations/24827165http://purl.uniprot.org/core/volume"34"xsd:string
http://purl.uniprot.org/citations/24827165http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24827165
http://purl.uniprot.org/citations/24827165http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/24827165
http://purl.uniprot.org/uniprot/P05067#attribution-578FFDC1DCB6F0A4E44820B4B11E959Ehttp://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_A0A0A0MRG2-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_P56817-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_P56818-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_A0A140VJC8-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_A0A218KGR2-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_A0A7P0TAB4-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_A0A8F9R5D5-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_A0A2I3BPT1-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_A0A2I3BQZ9-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165
http://purl.uniprot.org/uniprot/#_B4DGD0-mappedCitation-24827165http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24827165